We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$494B
AUM Growth
-$24.5B
Cap. Flow
-$42.4B
Cap. Flow %
-8.58%
Top 10 Hldgs %
29.31%
Holding
15,899
New
1,435
Increased
5,761
Reduced
6,731
Closed
1,760

Sector Composition

Rank Sector Weight
1 Technology 3.37%
2 Healthcare 3.33%
3 Consumer Discretionary 2.43%
4 Financials 2.27%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEHC icon
13576
GE HealthCare
GEHC
$32.4B
$2.65K ﹤0.01%
34
-2,210,418
-100% -$180M
FFIC
13577
PUT
DELISTED
Flushing Financial
FFIC
$2.63K ﹤0.01%
200
-1,200
-86% -$14.6K
NKGNW
13578
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$2.63K ﹤0.01%
26,526
+6,841
+35% +$716
NB
13579
CALL
NioCorp Developments
NB
$780M
$2.6K ﹤0.01%
+1,500
New +$3.5K
IRAAW
13580
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$2.58K ﹤0.01%
64,449
+15,000
+30% +$708
GLACR
13581
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$2.58K ﹤0.01%
12,290
-19,106
-61% -$4.34K
RCFA.WS
13582
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$2.58K ﹤0.01%
40,151
+3,715
+10% +$220
HUDAR
13583
DELISTED
Hudson Acquisition I Corp. Right
HUDAR
$2.55K ﹤0.01%
+10,628
New +$2.63K
LUXE
13584
CALL
LuxExperience B.V.
LUXE
$1.11B
$2.55K ﹤0.01%
500
-8,500
-94% -$39K
BHRB icon
13585
CALL
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$2.55K ﹤0.01%
+50
New +$2.55K
TXMD icon
13586
TherapeuticsMD
TXMD
$24M
$2.54K ﹤0.01%
1,576
-3,386
-68% -$6.84K
LUNG icon
13587
CALL
Pulmonx
LUNG
$87.6M
$2.54K ﹤0.01%
400
-800
-67% -$6.15K
DRH icon
13588
PUT
Diamondrock Hospitality Co
DRH
$2.56B
$2.54K ﹤0.01%
+300
New +$2.61K
AAPB icon
13589
PUT
GraniteShares 2x Long AAPL Daily ETF
AAPB
$17.2M
$2.53K ﹤0.01%
+100
New +$2.04K
BRKL
13590
CALL
DELISTED
Brookline Bancorp
BRKL
$2.5K ﹤0.01%
300
-2,300
-88% -$20.2K
NCMI icon
13591
National CineMedia
NCMI
$378M
$2.5K ﹤0.01%
570
-241,169
-100% -$1.16M
SJNK icon
13592
CALL
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
$2.5K ﹤0.01%
100
-2,100
-95% -$52.4K
PVL
13593
PUT
Permianville Royalty Trust
PVL
$57.1M
$2.49K ﹤0.01%
2,400
-2,300
-49% -$3.15K
LTRX icon
13594
CALL
Lantronix
LTRX
$266M
$2.48K ﹤0.01%
+700
New +$2.51K
CYTHW
13595
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$2.48K ﹤0.01%
10,793
-200
-2% -$49
HBNC icon
13596
CALL
Horizon Bancorp
HBNC
$1.04B
$2.47K ﹤0.01%
200
-5,100
-96% -$61.3K
CVGI icon
13597
PUT
Commercial Vehicle Group
CVGI
$147M
$2.45K ﹤0.01%
500
-100
-17% -$566
BIOR
13598
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$2.44K ﹤0.01%
+370
New +$2.52K
BCLI
13599
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.44K ﹤0.01%
480
+427
+806% +$3.2K
KTCC icon
13600
PUT
Key Tronic
KTCC
$44.7M
$2.43K ﹤0.01%
600
-600
-50% -$2.58K

Similar funds

Citadel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.

  • Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
  • Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
  • Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
  • Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
  • Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
  • Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
  • Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.